Catalog No.
RXX11501
Expression system
Mammalian Cells
Species reactivity
Bordetella pertussis (strain Tohama I / ATCC BAA-589 / NCTC 13251)
Host species
Human
Isotype
IgG1
Clonality
Monoclonal
Target
fhaB, FHA, Filamentous hemagglutinin
Concentration
3.84 mg/ml
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P12255
Applications
ELISA
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
T5
Effect of FHA and Prn on Bordetella pertussis colonization of mice is dependent on vaccine type and anatomical site., PMID:32822419
Screening and Genomic Characterization of Filamentous Hemagglutinin-Deficient Bordetella pertussis., PMID:29358336
Intranasal immunisation against tetanus with an attenuated Bordetella bronchiseptica vector expressing FrgC: improved immunogenicity using a Bvg-regulated promoter to express FrgC., PMID:15474722
Cloning and immunologic characterization of a truncated Bordetella bronchiseptica filamentous hemagglutinin fusion protein., PMID:10580199
Haemophilus ducreyi secretes a filamentous hemagglutinin-like protein., PMID:9811662
Antigenic analysis of Bordetella pertussis filamentous hemagglutinin with phage display libraries and rabbit anti-filamentous hemagglutinin polyclonal antibodies., PMID:9746593
Construction and characterization of Bordetella pertussis mutants lacking the vir-regulated P.69 outer membrane protein., PMID:1787793
Genetic characterization of Bordetella pertussis filamentous haemagglutinin: a protein processed from an unusually large precursor., PMID:2388559
For research use only. Not for human or drug use.
